Stroke study reveals key target for improving treatment and suggests that Gleevec may help

Sunday, June 22, 2008 - 14:07 in Health & Medicine

Research in mice shows why tPA carries risks as well as benefits, and suggests that Gleevec or other drugs could prevent problems For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net